MARKET

RGEN

RGEN

Repligen
NASDAQ
169.13
-9.48
-5.31%
After Hours: 169.13 0 0.00% 16:12 12/06 EST
OPEN
177.71
PREV CLOSE
178.61
HIGH
178.40
LOW
165.81
VOLUME
588.78K
TURNOVER
0
52 WEEK HIGH
274.09
52 WEEK LOW
137.21
MARKET CAP
9.39B
P/E (TTM)
58.47
1D
5D
1M
3M
1Y
5Y
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue?
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 5d ago
Declining Stock and Decent Financials: Is The Market Wrong About Repligen Corporation (NASDAQ:RGEN)?
It is hard to get excited after looking at Repligen's (NASDAQ:RGEN) recent performance, when its stock has declined 22...
Simply Wall St. · 11/21 15:03
Repligen Earnings Perspective: Return On Capital Employed
Benzinga · 11/09 14:54
Repligen Corporation to Present at Upcoming Investor Conferences
WALTHAM, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at two upcoming investor conferences. The Stifel 2022 Healthc...
GlobeNewswire · 11/08 12:30
--UBS Adjusts Repligen Price Target to $215 From $275, Maintains Buy Rating
--UBS Adjusts Repligen Price Target to $215 From $275, Maintains Buy Rating
MT Newswires · 11/02 10:31
Repligen (RGEN) Q3 Earnings and Revenues Top Estimates
Repligen (RGEN) delivered earnings and revenue surprises of 13.24% and 4.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/01 12:45
Recap: Repligen Q3 Earnings
Benzinga · 11/01 11:40
BRIEF-Repligen Corp Reports Quarterly Earnings Per Share Of $0.71
Reuters · 11/01 11:38
More
About RGEN
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, filtration; chromatography; process analytics; and proteins. The Filtration products are used in process development and process scale production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all monoclonal antibody (mAb) based drugs on the market.

Webull offers kinds of Repligen Corporation stock information, including NASDAQ:RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.